Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure-Reference-Cited by-同舟云学术

Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure

Published:2020-03 Issue: Volume:144 Page:141-147
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

de Meric de Bellefon Maïlys,Lemanski Claire,Castan Florence,Samalin Emmanuelle,Mazard Thibault,Lenglet Alexis,Demontoy Sylvain,Riou Olivier,Llacer-Moscardo Carmen,Fenoglietto Pascal,Aillères Norbert,Thezenas Simon,Debrigode Charles,Vieillot Sabine,Gourgou Sophie,Azria David

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I);Northover;Br J Cancer,2010

2. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

3. Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin;Gunderson;J Clin Oncol,2012

4. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study;Flam;J Clin Oncol,1996

5. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial;James;Lancet Oncol,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE;Digestive and Liver Disease;2024-07

2. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience;In Vivo;2024

3. Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer;Acta Oncologica;2023-07-28

4. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma;European Radiology;2023-07-18

5. One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus;International Journal of Radiation Oncology*Biology*Physics;2023-04